Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001946093 | SCV002211244 | uncertain significance | Fanconi anemia complementation group E | 2021-08-19 | criteria provided, single submitter | clinical testing | This sequence change replaces lysine with glutamic acid at codon 218 of the FANCE protein (p.Lys218Glu). The lysine residue is moderately conserved and there is a small physicochemical difference between lysine and glutamic acid. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with FANCE-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV001946093 | SCV002794254 | uncertain significance | Fanconi anemia complementation group E | 2021-11-04 | criteria provided, single submitter | clinical testing |